Cannabis Strategic Ventures (NUGS)
0.00
USD |
OTCM |
Apr 18, 16:00
Cannabis Strategic Ventures Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2020 | -42.19% |
March 31, 2020 | -1.07K% |
December 31, 2019 | -91.86% |
September 30, 2019 | -639.9% |
June 30, 2019 | -1.43K% |
March 31, 2019 | -2.55K% |
December 31, 2018 | |
September 30, 2018 | -3.21K% |
June 30, 2018 | -4.32K% |
March 31, 2018 | |
December 31, 2017 | -1.58K% |
September 30, 2017 | -18.22K% |
June 30, 2017 |
Date | Value |
---|---|
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
March 31, 2014 | 18.59% |
December 31, 2013 | 18.60% |
September 30, 2013 | 18.60% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.43K%
Minimum
Jun 2019
-42.19%
Maximum
Jun 2020
-655.5%
Average
-639.9%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Ampio Pharmaceuticals Inc | -- |